Clinical Trial Update: VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the VITAL study evaluating vitamins (homocysteine-lowering approach) to slow Alzheimer's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• VITAL vitamins (Homocysteine Study) (folic acid, vitamin B6, vitamin B12)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED